Oncology Clinical Trial
Official title:
Evaluation of the Effect of Individualized Nursing Care Based on the Professional Values Model for Parents of Pediatric Oncology Patients: A Randomized Controlled Trial
Objective: This study was planned to evaluate the effectiveness of individualized nursing care based on the Professional Values Model for parents of pediatric oncology patients. Method: Simple randomization will be used to evaluate the intervention and control groups. The sample of the study will be the parents of children aged 1-18 years (Intervention group: 35 parents, Control group: 35 parents) diagnosed with cancer in the Akdeniz University Hospital Pediatrics, Hematology and Oncology clinic and hospitalized. Portrait Values Questionnaire and PedsQL Health Care Satisfaction Hematology/Oncology Module Parent Form will be used to collect data. A 12-week individualized nursing care based on the Professional Values Model will be applied to 35 parents in the intervention group. The effectiveness of the program will be evaluated after all post-test applications are completed.
Status | Recruiting |
Enrollment | 70 |
Est. completion date | January 15, 2025 |
Est. primary completion date | September 14, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Being the parent of a pediatric oncology patient - Speak and understand Turkish Exclusion Criteria: - None |
Country | Name | City | State |
---|---|---|---|
Turkey | Akdeniz University | Antalya | |
Turkey | Akdeniz University | Antalya |
Lead Sponsor | Collaborator |
---|---|
Akdeniz University |
Turkey,
• Demirutku, K. Sümer, N. Temel degerlerin ölçümü: portre degerler anketinin türkçe uyarlamasi. Türk Psikoloji Yazilari, 2010; 13(25), 17-25
• Kürtüncü Tanir M, Kuguoglu S. Pediatrik Yasam Kalitesi Envanteri (PedsQL) Saglik Bakim Memnuniyeti Hematoloji/Onkoloji Modülü Ebeveyn Formu Geçerlik-Güvenirliligi. Ankara Saglik Hizmetleri Dergisi, 2012; 11(2).
• Schwartz, S. H., Melech, G., Lehmann, A., Burgess, S., Harris, M. ve Owens, V. (2001). Extending the cross-cultural validity of the theory of basic human values with a different method of measurement. Journal of Cross- Cultural Psychology, 32, 519-542.
Çiftcioglu, S., & Efe, E. (2017). Validity and Reliability of the Oral Assessment Guide for Children and Young People Receiving Chemotherapy. Turkish Journal of Oncology/Türk Onkoloji Dergisi, 32(4).
Harper FW, Peterson AM, Albrecht TL, Taub JW, Phipps S, Penner LA. Satisfaction with support versus size of network: differential effects of social support on psychological distress in parents of pediatric cancer patients. Psychooncology. 2016 May;25(5):551-8. doi: 10.1002/pon.3863. Epub 2015 Jun 17. — View Citation
Kaya A, Boz I. The development of the Professional Values Model in Nursing. Nurs Ethics. 2019 May;26(3):914-923. doi: 10.1177/0969733017730685. Epub 2017 Sep 20. — View Citation
Pai AL, Greenley RN, Lewandowski A, Drotar D, Youngstrom E, Peterson CC. A meta-analytic review of the influence of pediatric cancer on parent and family functioning. J Fam Psychol. 2007 Sep;21(3):407-15. doi: 10.1037/0893-3200.21.3.407. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Individual values awareness level | An increase in parents' awareness of their individual values is a measure of outcome. This increase will be measured by the "Portrait Values Questionnaire". The higher the average score, the higher the awareness of individual values. Statistical significance will be set at p < 0.05. One week after the "pre-test" for the intervention group, an "intermediate evaluation" will be made with the same measurement tool. In the interim evaluation, it will be evaluated whether there is an increase according to the pre-test score. 12 weeks after the "Portrait Values Questionnaire" and the "pretest", the same group will be given a "posttest" with the same measurement tool. In the post-test, it will be evaluated whether there is an increase in the mid-test and pre-test scores. If there is an increase in both "interim evaluation" and "post-test" scores compared to the "pretest" scores, it can be stated that the training program is effective on individual values. | Individual values awareness level of parent will be evaluated 3 times: pre-test, 1 week after the pre-test, and 12 weeks after the pre-test. The increase in both the mid-term and post-test scores in the 12-week period is the outcome measure. | |
Primary | Parent satisfaction level | The increase in the level of awareness of the satisfaction level of the parents is a measure of outcome. This increase will be measured by the "Pediatric Quality of Life Inventory Health Care Satisfaction Hematology/Oncology Module Parents Form". The higher the average score, the higher the parent satisfaction. Statistical significance will be set at p < 0.05. One week after the "pre-test" for the intervention group, an "intermediate evaluation" will be made with the same measurement tool. In the interim evaluation, it will be evaluated whether there is an increase according to the pre-test score. 12 weeks after the "pretest", the same group will be given a "posttest". In the post-test, it will be evaluated whether there is an increase in the mid-test and pre-test scores. If there is an increase in both "interim evaluation" and "post-test" scores compared to the "pretest" scores, it can be stated that the training program is effective on parent satisfaction. | Parent satisfaction level will be evaluated 3 times: pre-test, 1 week after the pre-test, and 12 weeks after the pre-test. The increase in both the mid-term and post-test scores in the 12-week period is the outcome measure. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01439152 -
Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors.
|
Phase 1 | |
Recruiting |
NCT05615246 -
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
|
||
Active, not recruiting |
NCT06015009 -
Symptom Management App for Children at the Early Stage of Cancer Survivorship and Their Caregivers
|
N/A | |
Active, not recruiting |
NCT03298100 -
Risk Scoring Model for Endometrial Cancer
|
||
Recruiting |
NCT05055609 -
Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors
|
Phase 1 | |
Not yet recruiting |
NCT04324320 -
Psychological Distress in Outpatient Oncological Rehabilitation
|
||
Completed |
NCT00588289 -
Long Term Follow-Up of Patients on Children's Cancer Group Protocols- (CCG-LTF1) FOLLOW-UP DATA
|
N/A | |
Recruiting |
NCT06222801 -
The 1st Tumor CytokinoTherapy Database (TCTD-1)
|
||
Recruiting |
NCT03831633 -
Comparative Effectiveness of AKYNZEO® and Standard of Care (Including EMEND®) for the Prevention of Nausea and Vomiting (CINV) in Cancer Patients
|
Phase 4 | |
Completed |
NCT04914702 -
Feasibility and Comparison of Continuously Monitored Vital Signs in Pediatric Patients With Cancer.
|
||
Recruiting |
NCT05198570 -
Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients
|
||
Recruiting |
NCT05712174 -
A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT03832062 -
Value of Analysing Under-utilised Leftover Tissue (VauLT)
|
||
Completed |
NCT03988777 -
Magnetic Seed Localisation for Nonpalpable Breast Lesions
|
||
Recruiting |
NCT06031233 -
Evaluating the Safety of Shortened Infusion Times for dIfferent Oncological Immunotherapie
|
Phase 4 | |
Enrolling by invitation |
NCT04019119 -
Digital Intervention for the Modification of Lifestyles (iGame)
|
N/A | |
Not yet recruiting |
NCT05926362 -
Capillary-Venous Paired Data Collection
|
||
Recruiting |
NCT05510856 -
Comparative Clinical Study Evaluating the Possible Efficacy of Duloxetine, Gabapentin and Lacosamide on Oxaliplatin-Induced Peripheral Neuropathy in Cancer Patients
|
Phase 4 | |
Recruiting |
NCT05686213 -
ExeNTrO: Exercise During Neoadjuvant Chemoradiation Treatment to Improve Rectal and Esophageal Cancer Outcome - Pilot Trial
|
Phase 2 | |
Completed |
NCT04180306 -
PEWS Implementation in an LMIC Setting
|
N/A |